This is a StreetInsider.com Premium Only Page

Orexigen Therapeutics (OREX) – Major News

Mar 12, 2018 05:54 AM Orexigen Therapeutics (OREX) to File Chapter 11 Bankruptcy

Nov 13, 2017 04:03 PM Orexigen Therapeutics (OREX) Tops Q3 EPS by 78c, Miss on Revenues

Aug 8, 2017 05:34 PM Orexigen Therapeutics (OREX) Reports Q2 Loss of $2.00/Share

May 9, 2017 04:40 PM Orexigen Therapeutics (OREX) Reports Q1 Loss of $4.67/Share

Mar 28, 2017 04:23 PM Orexigen Therapeutics (OREX) Misses Q4 EPS by 51c

Nov 3, 2016 04:58 PM Orexigen Therapeutics (OREX) Posts Q1 GAAP EPS of $1.12

Aug 4, 2016 06:17 PM Orexigen Therapeutics (OREX) Misses Q2 EPS by 26c

May 4, 2016 06:07 PM Orexigen Therapeutics (OREX) Tops Q1 EPS by 2c, Sales Miss

Feb 26, 2016 07:03 AM Orexigen Therapeutics (OREX) Misses Q4 EPS by 4c

Nov 5, 2015 04:07 PM Orexigen Therapeutics (OREX) Tops Q3 EPS by 7c, Revenue Misses

Aug 6, 2015 07:02 AM Orexigen Therapeutics (OREX) Misses Q2 EPS by 1c

May 8, 2015 07:05 AM Orexigen Therapeutics (OREX) Reports In-Line Q1 Loss of 14c/Share

Mar 26, 2015 02:24 PM Orexigen Therapeutics' (OREX) Mysimba Approved in Europe

Feb 25, 2015 06:31 AM Orexigen Therapeutics (OREX) Misses Q4 EPS by 21c

Nov 10, 2014 07:47 AM Orexigen Therapeutics (OREX) Tops Q3 EPS by 22c

Oct 20, 2014 08:08 AM Takeda and Orexigen (OREX) Announce Availability of CONTRAVE

Oct 20, 2014 08:07 AM Takeda, Orexigen Therapeutics (OREX) Announces Availability of CONTRAVE

Sep 11, 2014 07:04 AM Orexigen (OREX), Takeda Announce FDA Approval of Contrave Extended-Release Tablets

Aug 7, 2014 07:23 AM Orexigen Therapeutics, Inc. (OREX) Reports In-Line Q2 Loss of 21c/Share

Mar 12, 2014 04:02 PM Orexigen Therapeutics, Inc. (OREX) Posts Q4 Loss of 21c/Share

Nov 12, 2013 06:32 AM Orexigen Therapeutics, Inc. (OREX) Posts Q3 Loss of 19c/Share

Aug 6, 2013 04:08 PM Orexigen (OREX) Reports In-Line Q2 Loss; Plans European MAA for Contrave

Mar 13, 2013 04:03 PM Orexigen Therapeutics, Inc. (OREX) Tops Q4 EPS by 3c; Updates on Contrave

Nov 7, 2012 04:16 PM Orexigen Therapeutics, Inc. (OREX) Misses Q3 EPS by 14c

Oct 22, 2012 07:05 AM Orexigen (OREX) Said FDA Supports Faster Path to Resubmission of the Contrave NDA, Study Enrollment Surpasses 7K

Aug 7, 2012 07:31 AM Orexigen Therapeutics, Inc. (OREX) Posts Q2 Loss of 25c/Share, Wider than Views

May 9, 2012 04:00 PM Orexigen Therapeutics, Inc. (OREX) Misses Q1 EPS by 4c

Mar 8, 2012 04:01 PM Orexigen Therapeutics, Inc. (OREX) Posts Q4 Loss of 9c/Share

Aug 8, 2011 04:08 PM Orexigen Therapeutics, Inc. (OREX) Tops Q2 EPS by 4c

May 9, 2011 07:01 AM Orexigen Therapeutics, Inc. (OREX) Posts Mixed Q1 Results

Mar 10, 2011 04:02 PM Orexigen Therapeutics (OREX) Posts Narrower than Expected Q4 Loss

Feb 1, 2011 07:08 AM Orexigen (OREX) Shares Plummet as FDA Shows Concern for Long-Term Safety Profile of Contrave

Mar 9, 2010 07:26 AM Orexigen (OREX) Reports Q4 Loss of $0.32

Nov 4, 2009 05:46 PM Orexigen (OREX) Reports Q3 Loss of $0.33, Beats by 3c

Mar 12, 2009 04:13 PM Orexigen Therapeutics (OREX) Tops Q4 View By 5c

Aug 7, 2008 04:39 PM Orexigen Therapeutics (OREX) Reports In-Line Q2 Loss of $0.67

Mar 13, 2008 04:13 PM Orexigen Therapeutics (OREX) Reports Mixed Q4 Earnings